Non-alcoholic fatty liver diseasecolorectal cancerhepatic steatosisliver metastasisliver microenvironmentIntroduction: The liver is the most common metastatic site of colorectal cancer (CRC), and the long-term survival rate of CRC patients who cannot resect liver metastatic lesions radically is extremely ...
Pancreatic cancer is known as the most common asymptomatic as well as most lethal cancer in developed countries [2,3]. It is predicted that PC will be the leading cause of all cancer-related deaths by 2050 [4]. The connection between FP and PC has not been extensively studied; however, ...
Fatty liver, largely noted in obesity and hepatic cancer, is highly fatal and has led to a global increase in death rates. It is associated with complex metabolic reprogramming too. A standard approach to therapy in the newly diagnosed setting includes surgery or identification of biomarkers/ ...
44 In addition, CDHFD-fed mice also developed well to mimic human NAFLD and fibrosis disease.44 Because of its long duration, it has a high chance of progressing to liver cancer.45 Thus, we mainly used these 2 diets to induce NAFLD models. After being allowed to adapt for 5 days, the...
Non-alcoholic fatty liver disease (NAFLD) has been shown to influence breast cancer progression, but the underlying mechanisms remain unclear. In this study, we investigated the impact of NAFLD on breast cancer tumor growth and cell viability through the potential mediator, hepatic fibroblast growth ...
Objective: To evaluate the effects of comprehensive TCM intervention on peripheral symptoms and survival of patients with liver cancer in interventional tr... X Zhang,JY Dai - 《Hunan Journal of Traditional Chinese Medicine》 被引量: 3发表: 2012年 加载更多来源...
Worldwide, nonalcoholic fatty liver disease (NAFLD) has reached epidemic proportions and in parallel, hepatocellular carcinoma (HCC) has become one of the fastest growing cancers. Despite the rise in these disease entities, detailed long-term outcomes of
non-alcoholic fatty liver disease;non-alcoholic steatohepatitis;metabolic syndrome;cancer treatment;chemotherapy 1. Introduction Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide, affecting 5.5 million Australians, and 1 billion people globally [1,2]....
NASH is present. Isolated fatty liver does not progress to important liver disease. NASH, on the other hand, can progress through the formation of scar (fibrous tissue) tocirrhosis. The complications of cirrhosis, primarily gastrointestinal bleeding, liver failure, andliver cancer, then may occur....
Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver condition that affects a quarter of the global adult population. To date, only a few NAFLD risk prediction models have been developed for Chinese older adults aged ≥ 60 years. This study presented the development of a ...